4.6 Article

Use of pragmatic and explanatory trial designs in acute care research: lessons from COVID-19

Related references

Note: Only part of the references are listed.
News Item Medicine, General & Internal

Nature does things well

[Anonymous]

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)

Article Medicine, General & Internal

Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results

Summary: The authors of the study reported the interim results of using four repurposed antiviral drugs (remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a) in hospitalized COVID-19 patients. The study showed that these drug regimens had little or no effect on overall mortality, initiation of ventilation, and duration of hospital stay.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

D. M. Weinreich et al.

Summary: Recent data indicate that complications and death from Covid-19 may be related to high viral loads. In this trial involving nonhospitalized patients, a cocktail of two neutralizing monoclonal antibodies (REGN-COV2) reduced viral load, with a greater effect in patients with no immune response or high viral load at baseline. Safety outcomes were similar between REGN-COV2 dose groups and the placebo group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Editorial Material Medicine, General & Internal

Monoclonal Antibodies to Disrupt Progression of Early Covid-19 Infection

Myron S. Cohen

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

Summary: In a platform trial involving patients hospitalized with Covid-19, among 314 patients who were also being treated with remdesivir, those who received the monoclonal antibody LY-CoV555 did not have better pulmonary function at day 5 than those who received placebo. The trial was stopped for futility.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen et al.

Summary: LY-CoV555, a neutralizing antibody, showed promising results in reducing viral load, improving symptoms, and lowering the risk of hospitalization among patients with mild or moderate Covid-19. While one of the doses appeared to accelerate the decline in viral load, others did not show significant effects by day 11.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Editorial Material Medicine, General & Internal

Emerging Lessons From COVID-19 for the US Clinical Research Enterprise

Derek C. Angus et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

P. W. Horby et al.

Summary: Azithromycin has been proposed as a treatment for COVID-19 due to its immunomodulatory actions. However, a study in hospitalized patients with COVID-19 showed that azithromycin did not improve survival or other clinical outcomes. Its use should be restricted to patients with a clear antimicrobial indication.

LANCET (2021)

Review Biochemistry & Molecular Biology

mRNA vaccine for cancer immunotherapy

Lei Miao et al.

Summary: mRNA vaccines have emerged as a promising platform for cancer immunotherapy, showcasing high potency, safe administration, rapid development potentials, and cost-effective manufacturing. However, challenges such as stability, innate immunogenicity, and inefficient in vivo delivery restrict their applications. In addressing these challenges, structural modifications and formulation methods are being researched to enhance the anti-tumor immune response.

MOLECULAR CANCER (2021)

Article Medicine, General & Internal

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Noa Dagan et al.

Summary: A study conducted in Israel on nearly 600,000 individuals showed that the BNT162b2 mRNA vaccine was effective in reducing the risk of infection, hospitalization, and severe Covid-19. The effectiveness in preventing death was 72% during the period from day 14 through day 20 after the first dose, and hospitalization was reduced by 87% for the period 7 or more days after the second dose, similar to results from a randomized trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

Anthony C. Gordon et al.

Summary: Interleukin-6 receptor antagonists tocilizumab and sarilumab were found to improve outcomes, including survival, in critically ill patients with Covid-19 receiving organ support in ICUs according to an ongoing international trial. The efficacy of these treatments has been confirmed, with patients benefiting from the therapy.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

A Pragmatic, Randomized Clinical Trial of Gestational Diabetes Screening

Teresa A. Hillier et al.

Summary: In this study comparing one-step screening with two-step screening for gestational diabetes mellitus, the one-step approach resulted in more diagnoses of gestational diabetes mellitus but did not have a significant impact on the incidence of adverse perinatal and maternal outcomes.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Immunology

HIV mRNA Vaccines-Progress and Future Paths

Zekun Mu et al.

Summary: mRNA-based vaccines introduce a new approach by relying on host cells to produce antigenic proteins, offering a potential platform for protection against various diseases including HIV. This review explores the challenges of developing vaccines for HIV and outlines a vaccination strategy based on the immunology of broadly neutralizing antibody development.

VACCINES (2021)

Article Medicine, General & Internal

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Peter W. Horby et al.

Summary: Convalescent plasma therapy did not improve survival or other clinical outcomes in hospitalized COVID-19 patients.

LANCET (2021)

Article Medicine, General & Internal

Assessment of Length and Readability of Informed Consent Documents for COVID-19 Vaccine Trials

Ezekiel J. Emanuel et al.

Summary: The study found that current informed consent documents for COVID-19 vaccine trials are too long and complex, making them difficult to understand. By shortening the length and simplifying the language, the accessibility for participants can be improved.

JAMA NETWORK OPEN (2021)

Editorial Material Medicine, General & Internal

IL-6 Receptor Antagonist Therapy for Patients Hospitalized for COVID-19 Who, When, and How?

Michael A. Matthay et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Editorial Material Medicine, General & Internal

Is Learning Worth the Trouble? - Improving Health Care System Participation in Embedded Research

Richard Platt et al.

Summary: Embedded pragmatic clinical trials can help address important health issues by generating real-world evidence, avoiding the limitations associated with observational studies or conventional clinical trials such as time, expenses, and lack of generalizability.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

Ewan C. Goligher et al.

Summary: In critically ill patients with Covid-19, initial therapeutic-dose anticoagulation did not result in improved survival rates or fewer days requiring cardiovascular or respiratory organ support compared to usual-care pharmacologic thromboprophylaxis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Editorial Material Medicine, General & Internal

Proton Pump Inhibitors vs Histamine-2 Receptor Blockers for Stress Ulcer Prophylaxis in Critically Ill Patients Issues of Interpretability in Pragmatic Trials

Todd W. Rice et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Editorial Material Ethics

Consent for Acute Care Research and the Regulatory Gray Zone

Laura M. Beskow et al.

AMERICAN JOURNAL OF BIOETHICS (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US

Shruti Gupta et al.

JAMA INTERNAL MEDICINE (2020)

Article Critical Care Medicine

Subphenotypes in critical care: translation into clinical practice

Kiran Reddy et al.

Lancet Respiratory Medicine (2020)

Article Medicine, General & Internal

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

A. B. Cavalcanti et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19 A Randomized Clinical Trial

Pierre-Francois Dequin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Jonathan A. C. Sterne et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

Peter Horby et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Public, Environmental & Occupational Health

Validity of Acute Cardiovascular Outcome Diagnoses Recorded in European Electronic Health Records: A Systematic Review

Jennifer Davidson et al.

CLINICAL EPIDEMIOLOGY (2020)

Article Medicine, General & Internal

Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 A Randomized Clinical Trial

Wesley H. Self et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Critical Care Medicine

External Validity of Electronic Sniffers for Automated Recognition of Acute Respiratory Distress Syndrome

Andrew C. McKown et al.

JOURNAL OF INTENSIVE CARE MEDICINE (2019)

Article Medicine, General & Internal

Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018

Alexander C. Fanaroff et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Medicine, General & Internal

Bag-Mask Ventilation during Tracheal Intubation of Critically Ill Adults

Jonathan D. Casey et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Critical Care Medicine

Above the GRADE: Evaluation of Guidelines in Critical Care Medicine

Charles R. Sims et al.

CRITICAL CARE MEDICINE (2019)

Article Medicine, General & Internal

Balanced Crystalloids versus Saline in Noncritically Ill Adults

Wesley H. Self et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Medicine, General & Internal

Balanced Crystalloids versus Saline in Critically Ill Adults

Matthew W. Semler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Health Care Sciences & Services

A Systematic Review Of The Food And Drug Administration's 'Exception From Informed Consent' Pathway

William B. Feldman et al.

HEALTH AFFAIRS (2018)

Article Critical Care Medicine

Balanced Crystalloids versus Saline in the Intensive Care Unit The SALT Randomized Trial

Matthew W. Semler et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)

Article Critical Care Medicine

Randomized Trial of Video Laryngoscopy for Endotracheal Intubation of Critically Ill Adults

David R. Janz et al.

CRITICAL CARE MEDICINE (2016)

Article Critical Care Medicine

Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care

Theodore J. Iwashyna et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Article Medicine, Research & Experimental

Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials

John D. Lantos et al.

CLINICAL TRIALS (2015)

Article Medicine, General & Internal

The PRECIS-2 tool: designing trials that are fit for purpose

Kirsty Loudon et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Article Medicine, General & Internal

The PRECIS-2 tool: designing trials that are fit for purpose

Kirsty Loudon et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

Editorial Material Medicine, General & Internal

Ethics, Regulation, and Comparative Effectiveness Research Time for a Change

Richard Platt et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Article Medicine, General & Internal

Informed Consent, Comparative Effectiveness, and Learning Health Care

Ruth R. Faden et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Thrombus Aspiration during ST-Segment Elevation Myocardial Infarction

Ole Frobert et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Editorial Material Medicine, General & Internal

Addressing Low-Risk Comparative Effectiveness Research in Proposed Changes to US Federal Regulations Governing Research

Nancy Kass et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Article Medicine, General & Internal

Drotrecogin Alfa (Activated) in Adults with Septic Shock

V. Marco Ranieri et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Editorial Material Medicine, General & Internal

GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations

Gordon H. Guyatt et al.

BRITISH MEDICAL JOURNAL (2008)

Article Ethics

The therapeutic misconception at 25-Treatment, research, and confusion

Jonathan Kimmelman

HASTINGS CENTER REPORT (2007)

Review Medicine, General & Internal

Interventions to improve research participants' understanding in informed consent for research - A systematic review

J Flory et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)

Article Medicine, General & Internal

Statistics Notes - Blinding in clinical trials and other studies

SJ Day et al.

BRITISH MEDICAL JOURNAL (2000)

Review Medicine, General & Internal

What makes clinical research ethical?

EJ Emanuel et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)